Subscribe
ParinPix / Shutterstock.com
18 July 2024NewsAmericasMarisa Woutersen

USPTO clarifies AI's role in patent eligibility

Guidance says use of AI in inventing does not affect how patent claims are assessed for eligibility | Emphasis placed on evaluating inventions themselves rather than the method of creation | Updates include new examples to assist examiners in evaluating AI-related patent claims. 

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
‘Don’t stifle UK AI innovation’: King's speech on AI Act prompts warnings
16 July 2024   New bill anticipated to depart from previous government’s light-touch approach to AI regulation | Attorneys fear “onerous or conflicting” requirements on pharma and biotech companies.
Biotechnology
The patentability of AI-related inventions
25 January 2024   Despite the clamour for guidance, applicants, attorneys, and lawyers may be in for a frustrating wait before the UK updates AI protections, says Rebecca Lawrence of DLA Piper.


Editor's picks

Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024

Editor's picks

Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024

More on this story

Big Pharma
‘Don’t stifle UK AI innovation’: King's speech on AI Act prompts warnings
16 July 2024   New bill anticipated to depart from previous government’s light-touch approach to AI regulation | Attorneys fear “onerous or conflicting” requirements on pharma and biotech companies.
Biotechnology
The patentability of AI-related inventions
25 January 2024   Despite the clamour for guidance, applicants, attorneys, and lawyers may be in for a frustrating wait before the UK updates AI protections, says Rebecca Lawrence of DLA Piper.

More on this story

Big Pharma
‘Don’t stifle UK AI innovation’: King's speech on AI Act prompts warnings
16 July 2024   New bill anticipated to depart from previous government’s light-touch approach to AI regulation | Attorneys fear “onerous or conflicting” requirements on pharma and biotech companies.
Biotechnology
The patentability of AI-related inventions
25 January 2024   Despite the clamour for guidance, applicants, attorneys, and lawyers may be in for a frustrating wait before the UK updates AI protections, says Rebecca Lawrence of DLA Piper.

More features

Regeneron targets almost 50 patents in suit against Sandoz
Litigation implications of the USPTO’s terminal disclaimer proposal
High-tech expert joins White & Case in US expansion plan
Ipsen files further suit against CSPC over pancreatic cancer drug generic
Court recommends $54m judgment in Abbott TM case
Federal Circuit denies rehearing in heart valve case
FTC endorses greater access to affordable biosimilars
‘Still on the outside’: UPC says Abbott PI not valid in Ireland